The Effect of ASTARTE™ on Recurrent Urinary Tract Infection
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Investigate the effect of dietary supplements/probiotic ASTARTE™ ( L. crispatus, L. rhamnosus, L. jensenii, L. gasseri) on the microbiome composition in the intestine and vagina and thereby a reduction of risk factors for the development of rUTI during 6 months of intervention in women aged 18-40 years. This is measured by the incidence of symptomatic UTI.
Eligibility Criteria
Inclusion Criteria: * Women 18-40 years of age * Recurrent UTI (2 times UTI within 6 months or \> 3 times UTI infection within one year). * The subjects should be informed about the trial protocol. * The subject must be able to follow the protocol, have provided voluntary consent and have signed the declaration of consent. Exclusion Criteria: * Pregnancy or planning pregnancy * Breastfeeding * Participation in another trial with probiotic the last 30 days. * Hypersensitivity to any ingredient in the study product * Patients primarily admitted for a disorder other than UTI * Antibiotic treatment for any other condition than UTI at time of recruitment the last 30 days